These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 33724820)
21. Construction and screening of vast libraries of natural product-like macrocyclic peptides using in vitro display technologies. Bashiruddin NK; Suga H Curr Opin Chem Biol; 2015 Feb; 24():131-8. PubMed ID: 25483262 [TBL] [Abstract][Full Text] [Related]
22. Facile Synthesis of Dimeric Thioether-Macrocyclic Peptides with Antibody-like Affinity against Plexin-B1. Bashiruddin NK; Matsunaga Y; Nagano M; Takagi J; Suga H Bioconjug Chem; 2018 Jun; 29(6):1847-1851. PubMed ID: 29714478 [TBL] [Abstract][Full Text] [Related]
23. Peptoid macrocycles: making the rounds with peptidomimetic oligomers. Yoo B; Shin SB; Huang ML; Kirshenbaum K Chemistry; 2010 May; 16(19):5528-37. PubMed ID: 20414912 [TBL] [Abstract][Full Text] [Related]
24. Conformational analysis of drug-like molecules bound to proteins: an extensive study of ligand reorganization upon binding. Perola E; Charifson PS J Med Chem; 2004 May; 47(10):2499-510. PubMed ID: 15115393 [TBL] [Abstract][Full Text] [Related]
25. Discovery of Thioether-Cyclized Macrocyclic Covalent Inhibitors by mRNA Display. Lan T; Peng C; Yao X; Chan RST; Wei T; Rupanya A; Radakovic A; Wang S; Chen S; Lovell S; Snyder SA; Bogyo M; Dickinson BC J Am Chem Soc; 2024 Aug; 146(34):24053-24060. PubMed ID: 39136646 [TBL] [Abstract][Full Text] [Related]
26. Frontier Between Cyclic Peptides and Macrocycles. Ermert P; Luther A; Zbinden P; Obrecht D Methods Mol Biol; 2019; 2001():147-202. PubMed ID: 31134572 [TBL] [Abstract][Full Text] [Related]
27. Macrocycles All Aflutter: Substitution at an Allylic Center Reveals the Conformational Dynamics of [13]-Macrodilactones. Rutledge KM; Hamlin TA; Baldisseri DM; Bickelhaupt FM; Peczuh MW Chem Asian J; 2017 Oct; 12(19):2623-2633. PubMed ID: 28783877 [TBL] [Abstract][Full Text] [Related]
28. Constrained peptides with target-adapted cross-links as inhibitors of a pathogenic protein-protein interaction. Glas A; Bier D; Hahne G; Rademacher C; Ottmann C; Grossmann TN Angew Chem Int Ed Engl; 2014 Feb; 53(9):2489-93. PubMed ID: 24504455 [TBL] [Abstract][Full Text] [Related]
29. Macrocyclic drugs and clinical candidates: what can medicinal chemists learn from their properties? Giordanetto F; Kihlberg J J Med Chem; 2014 Jan; 57(2):278-95. PubMed ID: 24044773 [TBL] [Abstract][Full Text] [Related]
30. DNA-encoded chemical libraries of macrocycles. Connors WH; Hale SP; Terrett NK Curr Opin Chem Biol; 2015 Jun; 26():42-7. PubMed ID: 25710630 [No Abstract] [Full Text] [Related]
31. Accurate assessment of the strain energy in a protein-bound drug using QM/MM X-ray refinement and converged quantum chemistry. Fu Z; Li X; Merz KM J Comput Chem; 2011 Sep; 32(12):2587-97. PubMed ID: 21598285 [TBL] [Abstract][Full Text] [Related]
32. Towards understanding the unbound state of drug compounds: Implications for the intramolecular reorganization energy upon binding. Foloppe N; Chen IJ Bioorg Med Chem; 2016 May; 24(10):2159-89. PubMed ID: 27061672 [TBL] [Abstract][Full Text] [Related]
33. Docking of Macrocycles: Comparing Rigid and Flexible Docking in Glide. Alogheli H; Olanders G; Schaal W; Brandt P; Karlén A J Chem Inf Model; 2017 Feb; 57(2):190-202. PubMed ID: 28079375 [TBL] [Abstract][Full Text] [Related]
34. Macrocyclic α helical peptide therapeutic modality: A perspective of learnings and challenges. Sawyer TK; Partridge AW; Kaan HYK; Juang YC; Lim S; Johannes C; Yuen TY; Verma C; Kannan S; Aronica P; Tan YS; Sherborne B; Ha S; Hochman J; Chen S; Surdi L; Peier A; Sauvagnat B; Dandliker PJ; Brown CJ; Ng S; Ferrer F; Lane DP Bioorg Med Chem; 2018 Jun; 26(10):2807-2815. PubMed ID: 29598901 [TBL] [Abstract][Full Text] [Related]
35. Design, Properties and Recent Application of Macrocycles in Medicinal Chemistry. Ermert P Chimia (Aarau); 2017 Oct; 71(10):678-702. PubMed ID: 29070413 [TBL] [Abstract][Full Text] [Related]
36. The reorganization energy of compounds upon binding to proteins, from dynamic and solvated bound and unbound states. Foloppe N; Chen IJ Bioorg Med Chem; 2021 Dec; 51():116464. PubMed ID: 34798378 [TBL] [Abstract][Full Text] [Related]
37. PepExplainer: An explainable deep learning model for selection-based macrocyclic peptide bioactivity prediction and optimization. Zhai S; Tan Y; Zhu C; Zhang C; Gao Y; Mao Q; Zhang Y; Duan H; Yin Y Eur J Med Chem; 2024 Sep; 275():116628. PubMed ID: 38944933 [TBL] [Abstract][Full Text] [Related]
38. Thioether Macrocyclic Peptides Selected against TET1 Compact Catalytic Domain Inhibit TET1 Catalytic Activity. Nishio K; Belle R; Katoh T; Kawamura A; Sengoku T; Hanada K; Ohsawa N; Shirouzu M; Yokoyama S; Suga H Chembiochem; 2018 May; 19(9):979-985. PubMed ID: 29665240 [TBL] [Abstract][Full Text] [Related]
39. Cyclophilin Succumbs to a Macrocyclic Chameleon. Doak BC; Kihlberg J J Med Chem; 2018 Nov; 61(21):9469-9472. PubMed ID: 30359012 [TBL] [Abstract][Full Text] [Related]